DcR3 is a predictive factor in the adjuvant treatment of colorectal cancer.

被引：0
|
作者：
Rochlitz, C
Boulay, JL
Mild, G
Reuter, J
Terracciano, L
Gudat, F
Metzger, U
Laffer, U
Lowy, A
Stamm, B
Herrmann, R
机构：
[1] Swiss Grp Clin Canc Res, Bern, Switzerland
[2] Kantonsspital Basel, Basel, Switzerland
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
258PD
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] DcR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer
    Mild, G
    Bachmann, F
    Boulay, JL
    Glatz, K
    Laffer, U
    Lowy, A
    Metzger, U
    Reuter, J
    Terracciano, L
    Herrmann, R
    Rochlitz, C
    INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (03) : 254 - 257
  • [2] Expression of DcR3 in ovarian cancer and clinicopathological implication
    Chang, Y. H.
    Wang, P. H.
    Chen, Y. J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 341 - 342
  • [3] Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
    Su, Jingqian
    Tong, Zhiyong
    Wu, Shun
    Zhou, Fen
    Chen, Qi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [4] Adjuvant treatment in extreme elderly patients with colorectal cancer.
    Cuquerella, Marta Llopis
    Castaño, Maria del Carmen Ors
    Espinosa, Maria Ballester
    Cremades, Alejandra Magdaleno
    Aracil, Vicente Boix
    Belloch, Maria del Rocio Ramirez
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] A study of the efficacy of gastrimmune in the adjuvant treatment of colorectal cancer.
    Henwood, M
    Smith, AM
    Watson, SA
    Justin, T
    Michaeli, D
    Grimes, S
    Bush, D
    Scholefield, JH
    Hardcastle, JD
    GASTROENTEROLOGY, 2000, 118 (04) : A518 - A519
  • [6] DcR3, a new molecular target for the treatment of multiple sclerosis?
    Mueller, A. M.
    Pedre, X.
    Steinbrecher, A.
    MULTIPLE SCLEROSIS, 2007, 13 : S259 - S259
  • [7] Adjuvant chemotherapy for colorectal cancer.
    Demols A.
    Van Laethem J.L.
    Current Gastroenterology Reports, 2002, 4 (5) : 420 - 426
  • [8] DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus
    Han, Bing
    Bojalil, Rafael
    Amezcua-Guerra, Luis M.
    Springall, Rashidi
    Valderrama-Carvajal, Hector
    Wu, Jiangping
    Luo, Hongyu
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (08) : 1067 - 1075
  • [9] Are TWEAK and DcR3 molecular targets for the treatment of multiple sclerosis?
    Mueller, A. M.
    Pedre, X.
    Steinbrecher, A.
    MULTIPLE SCLEROSIS, 2007, 13 : S155 - S156
  • [10] DcR3 promotes proliferation and invasion of pancreatic cancer via a DcR3/STAT1/IRF1 feedback loop
    Wei, Yijun
    Chen, Xingyu
    Yang, Jian
    Yao, Jun
    Yin, Ni
    Zhang, Zixiang
    Li, Dechun
    Zhu, Dongming
    Zhou, Jian
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (12): : 2618 - +
12345